Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosis.
AUTOR(ES)
Smith, M J
RESUMO
Levels of ciprofloxacin in serum and sputum were studied for eight patients with cystic fibrosis who were infected with Pseudomonas aeruginosa. Patients were studied in a steady state on a dosage of 500 mg every 8 h. Peak levels in serum ranged from 1.27 to 5.6 mg/liter (mean, 3.16 +/- 1.27), and absorption was rapid, the time to peak concentration ranging from 0.5 to 3.0 h (mean, 1.5 +/- 0.9). The antibiotic penetrated sputum well, achieving areas under the curve of approximately 46% of those obtained in serum.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=176492Documentos Relacionados
- Pharmacokinetics of ciprofloxacin in cystic fibrosis.
- Azlocillin pharmacokinetics in patients with cystic fibrosis.
- Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis.
- Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis.
- Pharmacokinetics of aerosolized tobramycin in adult patients with cystic fibrosis.
